[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_2349",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_2349"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB01255"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "\"Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncratic reaction to sympathomimetic amines, glaucoma Agitated states Patients with a history of drug abuse During or within 14 days following the administration of monoamine oxidase inhibitors (hypertensive crises may result) [   See Drug Interactions (7.3)   Advanced arteriosclerosis (   4 Symptomatic cardiovascular disease (   4 Moderate to severe hypertension (   4 Hyperthyroidism (   4 Known hypersensitivity or idiosyncrasy to sympathomimetic amines (   4 Glaucoma (   4 Agitated states (   4 History of drug abuse (   4 During or within 14 days following the administration of monoamine oxidase inhibitors (MAOI) (   4   7.3\""
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/MedicalContraindication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB01255",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-08-23T13:00:18.351+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "aho1PoHFhoJFojcpMyQKZGb7HKyl149YlzPcaYrfwnZ81Sun1SF3GpfuHs5Jbdz5PsbPnsoShdoD7MDUAz3IHjncWvIhWhezpBs5DKHKs4M7Xbsckl0AjhHeTFOtdDLCA4eXJ3b96Ey6ZG7X4xbTyLkxhy6pSILf7RrHvn7S7iM="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAU7Sz6lsz8n_q_7AO3X6w6MgoSdAyw0XwJNb1AWGexqU#pubinfo"
} ]